Record Q1 Sales of $4.9 million, Record Q1 Net Earnings of $0.9 million MISSISSAUGA, February 10, 2022 - Microbix Biosystems Inc. (TSX:...

Helping Ensure Workflow Accuracy of Tests for Respiratory Viruses MISSISSAUGA, CANADA, February 1, 2022 – Microbix Biosystems Inc. (TSX:...

Follow-on Order from Government of Ontario Procurement Authorities MISSISSAUGA, CANADA, December 24, 2021 – Microbix Biosystems Inc. (TSX:...

Record Sales of $18.6 million, Record Net Earnings of $3.2 million MISSISSAUGA, December 23, 2021 - Microbix Biosystems Inc. (TSX: MBX,...

Helping Ensure Workflow Accuracy of Tests for COVID, Flu A, Flu B, and RSV MISSISSAUGA, CANADA, December 20, 2021 – Microbix Biosystems...

Helping Ensure Workflow Accuracy of PCR Tests for COVID “Variants of Concern” MISSISSAUGA, CANADA, November 17, 2021 – Microbix Biosystems...

Further Capital to Assist with Increasing Capacity and Efficiency MISSISSAUGA, CANADA, October 27, 2021 – Microbix Biosystems Inc. (TSX:...

$1.3 million balance repaid, improving cash flow and resulting in non-cash charge MISSISSAUGA, CANADA, October 4, 2021 – Microbix...

QAPs to Support Testing for COVID Viral Variants MISSISSAUGA, CANADA, September 27, 2021 – Microbix Biosystems Inc. (TSX: MBX, OTCQX:...

Record Sales of $5.5 million, Record Net Earnings of $1.5 million MISSISSAUGA, August 12, 2021 - Microbix Biosystems Inc. (TSX: MBX,...

Trading Upgrade to OTCQX Best Market and Torrey Hills Capital Engaged MISSISSAUGA, ON, August 3, 2021 – Microbix Biosystems Inc. (TSX:...

Two Abstracts Reporting on Cross-Platform Utility of Antigen & Serological QAPs™ MISSISSAUGA, CANADA, July 8, 2021 – Microbix...